Genitourinary Cancers Symposium Annual Meeting Coverage

Diabetes Ups Kidney Cancer Patient Death Risk

Diabetes Ups Kidney Cancer Patient Death Risk

Diabetes also found to increase cancer-specific mortality in patients with clear cell renal cell carcinoma.

Prostate Cancer Expectant Management On the Rise

Prostate Cancer Expectant Management On the Rise

Patients diagnosed with the cancer in 2011 were 2.5 times more likely to be managed expectantly than those diagnosed in 2004.

Kidney Cancer Survival Improved by BP Drugs

Kidney Cancer Survival Improved by BP Drugs

ACE inhibitors and angiotensin receptor blockers were shown to prolong median overall survival by nine months.

Lethal Prostate Cancer Less Likely in Men with AB Blood

Lethal Prostate Cancer Less Likely in Men with AB Blood

The risk of PCa death or distant metastases is 61% lower in men with blood group AB compared with those who have blood group O.

Non-Bone Metastases Increasing in mCRPC Patients

The rate of non-osseous metastasis increased significantly by 2.8% per year from 2000 to 2011.

Partial Nephrectomy Prolongs Survival in Younger Patients

The 10-year overall survival rate was 94% for partial nephrectomy compared with 89.7% for radical nephrectomy in patients aged 20-44.

Survival Rates Unchanged for Patients with Advanced RCC

Relative survival rates for patients with advanced renal cell carcinoma have not improved significantly in the era of targeted agents.

Salvage Brachytherapy Results Promising

Small case series shows benefit in patients with recurrent cancer in the prostate bed after radical prostatectomy.

Drugs for Metastatic Kidney Cancer Offer Similar Survival

Final overall survival data from a phase 3 trial reveal no significant difference between tivozanib and sorafenib.

Post-Cystectomy Chemotherapy Less Likely in Readmitted Patients

Bladder cancer patients readmitted to the hospital within 30 days of surgery were 30% less likely to receive post-operative chemotherapy.

Prostate Tumor Size Predicts Salvage Radiotherapy Outcomes

An maximal tumor diameter greater than 14 mm was associated with an eightfold increased risk of prostate cancer-specific mortality.

Anticoagulant Use May Improve Survival in mCRPC Patients

Risk of death is decreased by 37% in men receiving first-line docetaxel treatment.

Urologists a Key Factor in PCa Observation Underuse

Researchers speculate that patients opt for active treatment because of the influence of the diagnosing urologist.

ART for High-Risk Prostate Cancer Improves Outcomes

Adjuvant radiotherapy after radical prostatectomy decreased the likelihood biochemical failure.

Risk of Aggressive Prostate Cancer Higher in Blacks, Elderly

Compared with men younger than 50 years, men aged 75 and older had a nearly 9.4-fold increased risk of having high-risk disease, respectively.

Sign Up for Free e-newsletters